Uncontrolled signaling through the RAS-MAPK pathway drives oncogenesis and therapeutic resistance. Inhibiting SOS1 prevents the nucleotide exchange required for RAS to transition into its active state.

Background noise and overlapping signals in liquid media prevent accurate quantification of target analytes. Reducing these spectral artifacts ensures higher sensitivity and measurement precision.